The Rebirth of a Phoenix: Ovarian Cancers Are Addicted to ErbB-3

Gordon B. Mills, Yosef Yarden

    Research output: Contribution to journalShort survey

    14 Scopus citations


    Several cancer drugs intercept the ErbB family receptors EGFR (ErbB-1) and HER2 (ErbB-2). However, the therapeutic value of targeting ErbB-3 has been less clear. A report in this issue of Cancer Cell by Sheng et al. renews hopes that intercepting ErbB-3-mediated autocrine loops bears potential for treatment of ovarian cancer.

    Original languageEnglish (US)
    Pages (from-to)217-218
    Number of pages2
    JournalCancer Cell
    Issue number3
    StatePublished - Mar 16 2010


    ASJC Scopus subject areas

    • Oncology
    • Cell Biology
    • Cancer Research

    Cite this